Home » Analyst Articles – US
Cogent Biosciences (NASDAQ:COGT) Coverage Initiated by Analysts at Jefferies Financial Group
Jefferies Financial Group assumed coverage on shares of Cogent Biosciences (NASDAQ:COGT – Free Report) in a research report sent to investors on Monday morning, Marketbeat.com reports. The firm issued a buy rating and a $55.00... More of this article »
Morgan Stanley Issues Positive Forecast for Mondelez International (NASDAQ:MDLZ) Stock Price
Mondelez International (NASDAQ:MDLZ – Free Report) had its price target raised by Morgan Stanley from $66.00 to $70.00 in a research note published on Monday,Benzinga reports. Morgan Stanley currently has an overweight rating... More of this article »
Cognex (NASDAQ:CGNX) Price Target Raised to $64.00 at Barclays
Cognex (NASDAQ:CGNX – Free Report) had its price objective raised by Barclays from $61.00 to $64.00 in a research note published on Monday,Benzinga reports. Barclays currently has an overweight rating on the scientific and technical... More of this article »
Rocket Companies (NYSE:RKT) Upgraded by Keefe, Bruyette & Woods to “Outperform” Rating
Keefe, Bruyette & Woods upgraded shares of Rocket Companies (NYSE:RKT – Free Report) from a market perform rating to an outperform rating in a research report released on Monday morning, MarketBeat.com reports. Keefe, Bruyette... More of this article »
TD Securities Issues Positive Forecast for Wheaton Precious Metals (NYSE:WPM) Stock Price
Wheaton Precious Metals (NYSE:WPM – Free Report) had its target price raised by TD Securities from $164.00 to $165.00 in a report issued on Monday morning,Benzinga reports. The brokerage currently has a buy rating on the stock. Other... More of this article »
TD Cowen Issues Positive Forecast for Wheaton Precious Metals (NYSE:WPM) Stock Price
Wheaton Precious Metals (NYSE:WPM – Free Report) had its price objective boosted by TD Cowen from $164.00 to $165.00 in a research note released on Monday,Benzinga reports. The brokerage currently has a buy rating on the stock. A... More of this article »
Wheaton Precious Metals (NYSE:WPM) Price Target Raised to $178.00 at Scotiabank
Wheaton Precious Metals (NYSE:WPM – Free Report) had its price target boosted by Scotiabank from $175.00 to $178.00 in a research report report published on Monday,Benzinga reports. They currently have a sector outperform rating... More of this article »
Exxon Mobil (NYSE:XOM) Given New $163.00 Price Target at Barclays
Exxon Mobil (NYSE:XOM – Free Report) had its price target lifted by Barclays from $145.00 to $163.00 in a report published on Monday,Benzinga reports. Barclays currently has an overweight rating on the oil and gas company’s... More of this article »
Cohu (NASDAQ:COHU) Coverage Initiated by Analysts at Evercore
Evercore initiated coverage on shares of Cohu (NASDAQ:COHU – Free Report) in a report issued on Monday morning, MarketBeat Ratings reports. The brokerage issued an outperform rating and a $35.00 price objective on the semiconductor... More of this article »
OnKure Therapeutics (NASDAQ:OKUR) Price Target Lowered to $27.00 at HC Wainwright
OnKure Therapeutics (NASDAQ:OKUR – Free Report) had its target price cut by HC Wainwright from $34.00 to $27.00 in a report published on Monday morning,Benzinga reports. They currently have a buy rating on the stock. A number... More of this article »
Alnylam Pharmaceuticals (NASDAQ:ALNY) Given Hold Rating at Jefferies Financial Group
Jefferies Financial Group restated their hold rating on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) in a report released on Monday morning, Marketbeat.com reports. They currently have a $330.00 target price... More of this article »
Intuit (NASDAQ:INTU) Upgraded to Neutral at BNP Paribas Exane
BNP Paribas Exane upgraded shares of Intuit (NASDAQ:INTU – Free Report) from an underperform rating to a neutral rating in a research note released on Monday, MarketBeat Ratings reports. They currently have $463.00 target price... More of this article »
JFrog (NASDAQ:FROG) Now Covered by Guggenheim
Guggenheim initiated coverage on shares of JFrog (NASDAQ:FROG – Free Report) in a research note issued to investors on Monday morning, Marketbeat reports. The firm issued a buy rating and a $60.00 price objective on the stock. FROG... More of this article »
Simply Good Foods (NASDAQ:SMPL) Upgraded by Jefferies Financial Group to “Buy” Rating
Jefferies Financial Group upgraded shares of Simply Good Foods (NASDAQ:SMPL – Free Report) from a hold rating to a buy rating in a research report report published on Monday, Marketbeat.com reports. Jefferies Financial Group... More of this article »
Digimarc (NASDAQ:DMRC) Given New $10.00 Price Target at Needham & Company LLC
Digimarc (NASDAQ:DMRC – Free Report) had its price target trimmed by Needham & Company LLC from $20.00 to $10.00 in a research report released on Monday,Benzinga reports. The brokerage currently has a buy rating on the information... More of this article »
Royal Bank Of Canada Issues Positive Forecast for Micron Technology (NASDAQ:MU) Stock Price
Micron Technology (NASDAQ:MU – Free Report) had its target price increased by Royal Bank Of Canada from $425.00 to $525.00 in a research report report published on Monday morning,Benzinga reports. The firm currently has an outperform... More of this article »
Upstart (NASDAQ:UPST) Upgraded to Buy at BTIG Research
BTIG Research upgraded shares of Upstart (NASDAQ:UPST – Free Report) from a neutral rating to a buy rating in a research report sent to investors on Monday, Marketbeat reports. The brokerage currently has $43.00 price objective... More of this article »
Monster Beverage (NASDAQ:MNST) Price Target Lowered to $90.00 at Wells Fargo & Company
Monster Beverage (NASDAQ:MNST – Free Report) had its price objective lowered by Wells Fargo & Company from $94.00 to $90.00 in a report published on Monday morning, Marketbeat Ratings reports. Wells Fargo & Company... More of this article »
Summit Therapeutics (NASDAQ:SMMT) Downgraded by Jefferies Financial Group to “Hold”
Jefferies Financial Group lowered shares of Summit Therapeutics (NASDAQ:SMMT – Free Report) from a buy rating to a hold rating in a research report sent to investors on Monday morning, Marketbeat reports. The firm currently has... More of this article »
Alliant Energy (NASDAQ:LNT) Price Target Raised to $74.00 at Mizuho
Alliant Energy (NASDAQ:LNT – Free Report) had its target price upped by Mizuho from $73.00 to $74.00 in a research note published on Monday morning,Benzinga reports. The firm currently has a neutral rating on the stock. A number... More of this article »
Expedia Group (NASDAQ:EXPE) Receives Buy Rating from BTIG Research
BTIG Research restated their buy rating on shares of Expedia Group (NASDAQ:EXPE – Free Report) in a report issued on Monday,Benzinga reports. They currently have a $330.00 price target on the online travel company’s stock. EXPE... More of this article »
Jade Biosciences (NASDAQ:JBIO) Given New $39.00 Price Target at BTIG Research
Jade Biosciences (NASDAQ:JBIO – Free Report) had its price target upped by BTIG Research from $28.00 to $39.00 in a research report report published on Monday morning,Benzinga reports. They currently have a buy rating on the... More of this article »
Lindblad Expeditions (NASDAQ:LIND) Now Covered by Analysts at Oppenheimer
Oppenheimer began coverage on shares of Lindblad Expeditions (NASDAQ:LIND – Free Report) in a research note published on Monday, Marketbeat.com reports. The firm issued an outperform rating and a $25.00 price objective on the... More of this article »
Elemental Royalty (NASDAQ:ELE) Now Covered by HC Wainwright
HC Wainwright initiated coverage on shares of Elemental Royalty (NASDAQ:ELE – Free Report) in a research report released on Monday morning, MarketBeat reports. The firm issued a buy rating and a $32.50 price objective on the... More of this article »
Nextpower (NASDAQ:NXT) Given Buy Rating at Glj Research
Glj Research reiterated their buy rating on shares of Nextpower (NASDAQ:NXT – Free Report) in a research note released on Monday,Benzinga reports. Glj Research currently has a $147.33 target price on the stock. Other equities... More of this article »
Maze Therapeutics (NASDAQ:MAZE) Price Target Raised to $58.00 at Wedbush
Maze Therapeutics (NASDAQ:MAZE – Free Report) had its target price raised by Wedbush from $43.00 to $58.00 in a research report report published on Monday,Benzinga reports. Wedbush currently has an outperform rating on the stock. Several... More of this article »
Apogee Therapeutics (NASDAQ:APGE) Given Buy Rating at BTIG Research
BTIG Research reaffirmed their buy rating on shares of Apogee Therapeutics (NASDAQ:APGE – Free Report) in a report published on Monday morning,Benzinga reports. BTIG Research currently has a $137.00 price objective on the stock. Several... More of this article »
Design Therapeutics (NASDAQ:DSGN) Coverage Initiated by Analysts at Jefferies Financial Group
Jefferies Financial Group began coverage on shares of Design Therapeutics (NASDAQ:DSGN – Free Report) in a report released on Monday, MarketBeat.com reports. The brokerage issued a buy rating and a $15.00 target price on the... More of this article »
Solid Power (NASDAQ:SLDP) Coverage Initiated by Analysts at HC Wainwright
HC Wainwright began coverage on shares of Solid Power (NASDAQ:SLDP – Free Report) in a report released on Monday morning, Marketbeat.com reports. The brokerage issued a buy rating and a $7.00 price objective on the stock. Several... More of this article »
Immunocore (NASDAQ:IMCR) Lowered to Hold Rating by Jefferies Financial Group
Jefferies Financial Group lowered shares of Immunocore (NASDAQ:IMCR – Free Report) from a buy rating to a hold rating in a research report released on Monday, Marketbeat reports. They currently have $33.00 price target on the... More of this article »
Palantir Technologies’ (PLTR) Outperform Rating Reaffirmed at Wedbush
Wedbush restated their outperform rating on shares of Palantir Technologies (NASDAQ:PLTR – Free Report) in a research note released on Monday,Benzinga reports. They currently have a $230.00 price target on the stock. A number... More of this article »
Silvaco Group (NASDAQ:SVCO) Given “Buy” Rating at Needham & Company LLC
Needham & Company LLC reiterated their buy rating on shares of Silvaco Group (NASDAQ:SVCO – Free Report) in a research note released on Monday,Benzinga reports. The brokerage currently has a $10.00 target price on the stock. Several... More of this article »
Molecular Partners (NASDAQ:MOLN) Receives “Buy” Rating from HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Molecular Partners (NASDAQ:MOLN – Free Report) in a report published on Monday,Benzinga reports. They currently have a $13.00 price target on the stock. Several other equities... More of this article »
Wealthfront (NASDAQ:WLTH) Price Target Lowered to $17.00 at Citizens Jmp
Wealthfront (NASDAQ:WLTH – Free Report) had its target price reduced by Citizens Jmp from $20.00 to $17.00 in a research note published on Monday,Benzinga reports. Citizens Jmp currently has a market outperform rating on the... More of this article »
Incyte (NASDAQ:INCY) Downgraded by Jefferies Financial Group to Hold
Jefferies Financial Group cut shares of Incyte (NASDAQ:INCY – Free Report) from a buy rating to a hold rating in a research report released on Monday, Marketbeat.com reports. They currently have $94.00 price objective on the... More of this article »
Atlassian (NASDAQ:TEAM) Now Covered by BNP Paribas Exane
BNP Paribas Exane initiated coverage on shares of Atlassian (NASDAQ:TEAM – Free Report) in a research note released on Monday morning, Marketbeat reports. The brokerage issued an outperform rating and a $95.00 price objective... More of this article »
Opus Genetics (NASDAQ:IRD) Now Covered by Oppenheimer
Oppenheimer started coverage on shares of Opus Genetics (NASDAQ:IRD – Free Report) in a report published on Monday, MarketBeat reports. The firm issued an outperform rating and a $10.00 target price on the stock. Several other... More of this article »
The Hain Celestial Group (NASDAQ:HAIN) Lowered to Underweight Rating by Barclays
Barclays cut shares of The Hain Celestial Group (NASDAQ:HAIN – Free Report) from an equal weight rating to an underweight rating in a report released on Monday morning, Marketbeat reports. Barclays currently has $0.50 price target... More of this article »
Turtle Beach (NASDAQ:TBCH) Given New $11.00 Price Target at Wedbush
Turtle Beach (NASDAQ:TBCH – Free Report) had its target price decreased by Wedbush from $14.00 to $11.00 in a report published on Monday,Benzinga reports. Wedbush currently has a neutral rating on the stock. A number of other... More of this article »
KLA (NASDAQ:KLAC) Given Buy Rating at Needham & Company LLC
Needham & Company LLC restated their buy rating on shares of KLA (NASDAQ:KLAC – Free Report) in a research report released on Monday,Benzinga reports. The brokerage currently has a $1,800.00 price objective on the semiconductor... More of this article »
Prenetics Global (NASDAQ:PRE) Now Covered by Lake Street Capital
Lake Street Capital started coverage on shares of Prenetics Global (NASDAQ:PRE – Free Report) in a research report sent to investors on Monday, Marketbeat reports. The firm issued a buy rating and a $29.00 price target on the... More of this article »
Xenon Pharmaceuticals (NASDAQ:XENE) Given New $63.00 Price Target at Wedbush
Xenon Pharmaceuticals (NASDAQ:XENE – Free Report) had its price target cut by Wedbush from $64.00 to $63.00 in a report published on Monday morning,Benzinga reports. They currently have an outperform rating on the biopharmaceutical... More of this article »
MediciNova (NASDAQ:MNOV) Now Covered by Analysts at HC Wainwright
HC Wainwright assumed coverage on shares of MediciNova (NASDAQ:MNOV – Free Report) in a research report report published on Monday, MarketBeat reports. The firm issued a buy rating and a $10.00 price target on the biopharmaceutical... More of this article »
Zevra Therapeutics (NASDAQ:ZVRA) Now Covered by Analysts at BTIG Research
BTIG Research assumed coverage on shares of Zevra Therapeutics (NASDAQ:ZVRA – Free Report) in a research note published on Monday morning, MarketBeat reports. The firm issued a buy rating and a $23.00 target price on the stock. Several... More of this article »
BeOne Medicines (NASDAQ:ONC) Downgraded by Jefferies Financial Group to Hold
Jefferies Financial Group cut shares of BeOne Medicines (NASDAQ:ONC – Free Report) from a buy rating to a hold rating in a research note released on Monday, Marketbeat.com reports. The firm currently has $290.00 price objective... More of this article »
Trade Desk (NASDAQ:TTD) Upgraded by Arete Research to Neutral Rating
Arete Research upgraded shares of Trade Desk (NASDAQ:TTD – Free Report) from a sell rating to a neutral rating in a research report sent to investors on Monday, MarketBeat reports. They currently have $25.00 price target on the... More of this article »
Carvana (NYSE:CVNA) Receives Buy Rating from Needham & Company LLC
Needham & Company LLC restated their buy rating on shares of Carvana (NYSE:CVNA – Free Report) in a report published on Monday morning,Benzinga reports. Needham & Company LLC currently has a $500.00 price target on... More of this article »
Devon Energy (NYSE:DVN) Price Target Raised to $54.00 at Barclays
Devon Energy (NYSE:DVN – Free Report) had its price objective lifted by Barclays from $52.00 to $54.00 in a report released on Monday,Benzinga reports. They currently have an overweight rating on the energy company’s stock. DVN... More of this article »